The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

DELIRIUM AS A COMPLICATION OF IMIPRAMINE THERAPY IN THE AGED

Published Online:https://doi.org/10.1176/ajp.120.5.502

Tofrānil may well have value in the treatment of depressive responses in the aged and in those with organic reactions, as Kuhn and others have suggested; but the dosage should be reduced and the patient observed for signs of delirium.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.